A phase II dose-ranging study of sitamaquine for the treatment of visceral leishmaniasis in India. - Jha,T.K.; Sundar,S.; Thakur,C.P.; Felton,J.M.; Sabin,A.J.; Horton,J. (Am J Trop Med Hyg, 2005)